Rockwell Medical Technologies (RMTI) 11.17 $RMTI
Stay Away From Financials - Cramer's Lightning Round (1/30/15)
SA Editor Mohit Manghnani - Seeking Alpha - Mon Feb 02, 4:37AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Friday, January 30. Bullish Calls: FireEye (NASDAQ: FEYE ): " I like FireEye, I like the whole segment." Vector Group (NYSE: VGR ): " I like...
WFM: 56.15 (-0.15), HAIN: 59.48 (+0.45), FEYE: 42.26 (+2.63), SWKS: 81.85 (-0.57), ALLY: 22.05 (+0.21), GWPH: 78.09 (+1.70), AON: 100.56 (-0.18), STKL: 11.59 (-0.07), RMTI: 11.17 (+0.15), SIMO: 29.08 (-0.39), VGR: 22.52 (-0.26)
'Mad Money' Lightning Round: I'm in GW Pharmaceuticals for the Long Term
at The Street - Sat Jan 31, 5:00AM CST
Cramer likes FireEye, does not like Rockwell Medical and is staying away from Ally Financial and Aon.
WFM: 56.15 (-0.15), HAIN: 59.48 (+0.45), FEYE: 42.26 (+2.63), SWKS: 81.85 (-0.57), GWPH: 78.09 (+1.70), ALLY: 22.05 (+0.21), STKL: 11.59 (-0.07), AON: 100.56 (-0.18), RMTI: 11.17 (+0.15), SIMO: 29.08 (-0.39), VGR: 22.52 (-0.26)
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
at The Street - Fri Jan 30, 7:14PM CST
Cramer will be watching earnings from Exxon Mobil, General Motors and Buffalo Wild Wings, among many others.
WFM: 56.15 (-0.15), SHAK: 40.69 (+0.04), FEYE: 42.26 (+2.63), SWKS: 81.85 (-0.57), CLX: 109.00 (+0.74), ALLY: 22.05 (+0.21), XOM: 93.37 (+1.00), DIS: 104.17 (+0.59), STKL: 11.59 (-0.07), AON: 100.56 (-0.18), RMTI: 11.17 (+0.15), BWLD: 187.27 (+0.30), NOV: 53.36 (+0.80), HAIN: 59.48 (+0.45), GWPH: 78.09 (+1.70), BOOT: 23.04 (-0.52), CMG: 674.89 (+4.60), GM: 37.62 (-0.40), BP: 41.93 (+0.59), GOOGL: 551.16 (+5.15), TWTR: 48.50 (+0.55), SIMO: 29.08 (-0.39), VGR: 22.52 (-0.26), APC: 89.44 (+2.13)
Seeking Alpha's Biotech Weekly: Intercept Pops, Provenge's Prince Valeant, And More
SA Editor Mike Taylor - at Seeking Alpha - Fri Jan 30, 3:00PM CST
BCRX: 10.06 (-0.09), ACT: 285.37 (+3.71), VRX: 167.00 (-0.50), PCYC: 163.28 (+0.23), ZSPH: 46.77 (+3.42), RMTI: 11.17 (+0.15), BCLI: 3.86 (-0.02), SIEN: 15.90 (+0.38), JNJ: 99.62 (+1.18), ECYT: 5.26 (-0.02), SNY: 49.42 (+0.82), LENS: 6.00 (-0.67), REGN: 402.40 (+0.66), SYK: 94.51 (+1.14), PFE: 34.64 (-0.23), SLXP: 152.35 (+3.17), AMGN: 153.48 (+0.30), APPY: 0.45 (-0.01), MNKD: 7.00 (+0.02), CELG: 115.88 (+0.16), ISRG: 510.73 (+3.02), GILD: 101.90 (+1.10), ANIP: 62.69 (-0.43), MRK: 58.81 (-0.07), ALXN: 182.29 (+6.02), CCXI: 7.85 (+0.04), ICPT: 209.12 (+7.12), AEZS: 0.53 (unch), ATRS: 2.45 (+0.05), NASH: 31.48 (+0.01)
Use Options For A Chance To Buy RMTI At A 37% Discount
at The Street - Thu Jan 29, 10:44AM CST
Looking back to 71 days ago, Rockwell Medical, Inc priced a 6,500,000 share secondary stock offering at $9.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the...
RMTI: 11.17 (+0.15)
Rockwell Medical: Triferic Approved And The Stock Is Down, Now What?
ONeil Trader - at Seeking Alpha - Wed Jan 28, 2:27PM CST
RMTI: 11.17 (+0.15)
Caterpillar and Microsoft are big market movers
AP - Tue Jan 27, 3:32PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:
RKT: 70.00 (+0.69), OLED: 35.57 (+0.32), SWY: 35.10 (-0.04), LSCC: 6.10 (+0.02), JJSF: 100.08 (-0.44), OCN: 9.10 (+0.09), RMTI: 11.17 (+0.15), HCA: 68.54 (-0.48), MAT: 27.61 (+0.17), SIMG: 7.25 (-0.01), AAL: 48.39 (+0.51), CAT: 85.13 (+1.60), PG: 85.90 (-0.13), MSFT: 43.87 (+0.78)
Rockwell Medical (RMTI) Stock Higher Today After FDA Approves Iron Replacement Drug
at The Street - Mon Jan 26, 9:17AM CST
Shares of Rockwell Medical (RMTI) are up after the FDA approved the company's drug Triferic, which is used for treating iron loss in chronic kidney disease patients on dialysis.
RMTI: 11.17 (+0.15)
Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Mon Jan 26, 8:14AM CST
RKT: 70.00 (+0.69), DHI: 27.19 (-0.15), OLED: 35.57 (+0.32), OIBR: 2.49 (+0.34), BDR: 1.71 (-0.02), ASPS: 22.32 (+0.09), OCN: 9.10 (+0.09), STX: 61.83 (+0.67), LACO: 8.38 (+0.17), HWAY: 21.32 (+0.01), GTI: 4.16 (+0.32), NBG: 1.61 (+0.18), FXCM: 2.21 (-0.01), RMTI: 11.17 (+0.15), BCLI: 3.86 (-0.02), MAT: 27.61 (+0.17), MWV: 53.91 (+0.59), GNRC: 49.89 (+0.29), CTP: 6.53 (+0.13), RGP: 24.49 (+0.36), CNET: 1.58 (+0.02), HLSS: 16.15 (-0.14)
FDA clears Triferic
Seeking Alpha - at Seeking Alpha - Mon Jan 26, 7:22AM CST
RMTI: 11.17 (+0.15)
U.S. FDA Approves Rockwell's Triferic(TM) for Iron Replacement and Maintenance of Hemoglobin in Hemodialysis Patients
GlobeNewswire - Mon Jan 26, 7:10AM CST
Rockwell Medical, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis, announced today that the U.S. Food & Drug Administration (FDA) has approved its drug Triferic for commercial sale as an iron replacement product to maintain hemoglobin in adult patients with hemodialysis dependent chronic kidney disease.
RMTI: 11.17 (+0.15)
Convert Catalysts Into Profits: Sagient Research's Edward Stopke
Life Sciences Report - Seeking Alpha - Fri Jan 23, 7:51AM CST
The biotech sector is teeming with companies racing to bring the hot new drug or therapy to the marketplace. But realistically assessing the therapeutic potential of pipeline products is the healthy approach for selecting a winner. In this interview...
CPXX: 3.10 (+0.07), RPTP: 9.05 (-0.40), SRPT: 12.76 (+0.11), CLDX: 20.97 (+0.53), PTCT: 53.37 (-0.74), RMTI: 11.17 (+0.15), ATHX: 2.12 (unch), CUR: 3.41 (+0.13)
PDUFA date approaches for Rockwell's Triferic
Seeking Alpha - at Seeking Alpha - Thu Jan 22, 12:19PM CST
RMTI: 11.17 (+0.15)
Rockwell Medical Technologies Shares Up 17.6% Since SmarTrend's Buy Recommendation (RMTI)
Comtex SmarTrend(R) - Thu Jan 15, 9:33AM CST
SmarTrend identified an Uptrend for Rockwell Medical Technologies (NASDAQ:RMTI) on December 31st, 2014 at $10.07. In approximately 2 weeks, Rockwell Medical Technologies has returned 17.64% as of today's recent price of $11.84.
RMTI: 11.17 (+0.15)
NxStage Revises Up 2014 Guidance on Strong Home Growth - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 14, 4:15PM CST
NxStage Medical Inc. (NXTM) revised its fourth quarter and full year 2014 guidance.
NXTM: 17.56 (-0.05), BAX: 70.39 (+0.31), FMS: 36.43 (-0.65), RMTI: 11.17 (+0.15)
Rockwell Medical (RMTI) Jumps: Stock Moves 8.7% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 08, 8:25AM CST
Rockwell Medical (RMTI) was a big mover last session, with shares rising nearly 9% on the day.
ICUI: 88.98 (+0.42), RMTI: 11.17 (+0.15)
Rockwell Medical Announces Two Triferic Abstracts to be Presented at Annual Dialysis Conference Jan. 31 - Feb. 3, 2015 in New Orleans, Louisiana
GlobeNewswire - Wed Jan 07, 7:00AM CST
Rockwell Medical, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis, announced today that two individual abstracts for Triferic have been selected by the Annual Dialysis Conference for presentation at their Annual Meeting, January 31 - February 3, 2015 in New Orleans, Louisiana. Triferic is the Company's late-stage investigational iron-replacement drug for the treatment of iron deficiency in chronic kidney disease patients receiving hemodialysis.
RMTI: 11.17 (+0.15)
Nasdaq stocks posting largest percentage increases
AP - Tue Dec 30, 5:31PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
RESN: 16.62 (-1.38), ADXS: 7.18 (+0.06), ARWR: 6.77 (+0.21), LAKE: 10.18 (+0.89), RMTI: 11.17 (+0.15), ASYS: 9.87 (+0.30), SZMK: 6.53 (+0.10)
Stay Away From Financials - Cramer's Lightning Round (1/30/15)
SA Editor Mohit Manghnani - Seeking Alpha - Mon Feb 02, 4:37AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Friday, January 30. Bullish Calls: FireEye (NASDAQ: FEYE ): " I like FireEye, I like the whole segment." Vector Group (NYSE: VGR ): " I like...
WFM: 56.15 (-0.15), HAIN: 59.48 (+0.45), FEYE: 42.26 (+2.63), SWKS: 81.85 (-0.57), ALLY: 22.05 (+0.21), GWPH: 78.09 (+1.70), AON: 100.56 (-0.18), STKL: 11.59 (-0.07), RMTI: 11.17 (+0.15), SIMO: 29.08 (-0.39), VGR: 22.52 (-0.26)
'Mad Money' Lightning Round: I'm in GW Pharmaceuticals for the Long Term
at The Street - Sat Jan 31, 5:00AM CST
Cramer likes FireEye, does not like Rockwell Medical and is staying away from Ally Financial and Aon.
WFM: 56.15 (-0.15), HAIN: 59.48 (+0.45), FEYE: 42.26 (+2.63), SWKS: 81.85 (-0.57), GWPH: 78.09 (+1.70), ALLY: 22.05 (+0.21), STKL: 11.59 (-0.07), AON: 100.56 (-0.18), RMTI: 11.17 (+0.15), SIMO: 29.08 (-0.39), VGR: 22.52 (-0.26)
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
at The Street - Fri Jan 30, 7:14PM CST
Cramer will be watching earnings from Exxon Mobil, General Motors and Buffalo Wild Wings, among many others.
WFM: 56.15 (-0.15), SHAK: 40.69 (+0.04), FEYE: 42.26 (+2.63), SWKS: 81.85 (-0.57), CLX: 109.00 (+0.74), ALLY: 22.05 (+0.21), XOM: 93.37 (+1.00), DIS: 104.17 (+0.59), STKL: 11.59 (-0.07), AON: 100.56 (-0.18), RMTI: 11.17 (+0.15), BWLD: 187.27 (+0.30), NOV: 53.36 (+0.80), HAIN: 59.48 (+0.45), GWPH: 78.09 (+1.70), BOOT: 23.04 (-0.52), CMG: 674.89 (+4.60), GM: 37.62 (-0.40), BP: 41.93 (+0.59), GOOGL: 551.16 (+5.15), TWTR: 48.50 (+0.55), SIMO: 29.08 (-0.39), VGR: 22.52 (-0.26), APC: 89.44 (+2.13)
Seeking Alpha's Biotech Weekly: Intercept Pops, Provenge's Prince Valeant, And More
SA Editor Mike Taylor - at Seeking Alpha - Fri Jan 30, 3:00PM CST
BCRX: 10.06 (-0.09), ACT: 285.37 (+3.71), VRX: 167.00 (-0.50), PCYC: 163.28 (+0.23), ZSPH: 46.77 (+3.42), RMTI: 11.17 (+0.15), BCLI: 3.86 (-0.02), SIEN: 15.90 (+0.38), JNJ: 99.62 (+1.18), ECYT: 5.26 (-0.02), SNY: 49.42 (+0.82), LENS: 6.00 (-0.67), REGN: 402.40 (+0.66), SYK: 94.51 (+1.14), PFE: 34.64 (-0.23), SLXP: 152.35 (+3.17), AMGN: 153.48 (+0.30), APPY: 0.45 (-0.01), MNKD: 7.00 (+0.02), CELG: 115.88 (+0.16), ISRG: 510.73 (+3.02), GILD: 101.90 (+1.10), ANIP: 62.69 (-0.43), MRK: 58.81 (-0.07), ALXN: 182.29 (+6.02), CCXI: 7.85 (+0.04), ICPT: 209.12 (+7.12), AEZS: 0.53 (unch), ATRS: 2.45 (+0.05), NASH: 31.48 (+0.01)
Use Options For A Chance To Buy RMTI At A 37% Discount
at The Street - Thu Jan 29, 10:44AM CST
Looking back to 71 days ago, Rockwell Medical, Inc priced a 6,500,000 share secondary stock offering at $9.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the...
RMTI: 11.17 (+0.15)
Rockwell Medical: Triferic Approved And The Stock Is Down, Now What?
ONeil Trader - at Seeking Alpha - Wed Jan 28, 2:27PM CST
RMTI: 11.17 (+0.15)
Caterpillar and Microsoft are big market movers
AP - Tue Jan 27, 3:32PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:
RKT: 70.00 (+0.69), OLED: 35.57 (+0.32), SWY: 35.10 (-0.04), LSCC: 6.10 (+0.02), JJSF: 100.08 (-0.44), OCN: 9.10 (+0.09), RMTI: 11.17 (+0.15), HCA: 68.54 (-0.48), MAT: 27.61 (+0.17), SIMG: 7.25 (-0.01), AAL: 48.39 (+0.51), CAT: 85.13 (+1.60), PG: 85.90 (-0.13), MSFT: 43.87 (+0.78)
Rockwell Medical (RMTI) Stock Higher Today After FDA Approves Iron Replacement Drug
at The Street - Mon Jan 26, 9:17AM CST
Shares of Rockwell Medical (RMTI) are up after the FDA approved the company's drug Triferic, which is used for treating iron loss in chronic kidney disease patients on dialysis.
RMTI: 11.17 (+0.15)
Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Mon Jan 26, 8:14AM CST
RKT: 70.00 (+0.69), DHI: 27.19 (-0.15), OLED: 35.57 (+0.32), OIBR: 2.49 (+0.34), BDR: 1.71 (-0.02), ASPS: 22.32 (+0.09), OCN: 9.10 (+0.09), STX: 61.83 (+0.67), LACO: 8.38 (+0.17), HWAY: 21.32 (+0.01), GTI: 4.16 (+0.32), NBG: 1.61 (+0.18), FXCM: 2.21 (-0.01), RMTI: 11.17 (+0.15), BCLI: 3.86 (-0.02), MAT: 27.61 (+0.17), MWV: 53.91 (+0.59), GNRC: 49.89 (+0.29), CTP: 6.53 (+0.13), RGP: 24.49 (+0.36), CNET: 1.58 (+0.02), HLSS: 16.15 (-0.14)
FDA clears Triferic
Seeking Alpha - at Seeking Alpha - Mon Jan 26, 7:22AM CST
RMTI: 11.17 (+0.15)
U.S. FDA Approves Rockwell's Triferic(TM) for Iron Replacement and Maintenance of Hemoglobin in Hemodialysis Patients
GlobeNewswire - Mon Jan 26, 7:10AM CST
Rockwell Medical, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis, announced today that the U.S. Food & Drug Administration (FDA) has approved its drug Triferic for commercial sale as an iron replacement product to maintain hemoglobin in adult patients with hemodialysis dependent chronic kidney disease.
RMTI: 11.17 (+0.15)
Convert Catalysts Into Profits: Sagient Research's Edward Stopke
Life Sciences Report - Seeking Alpha - Fri Jan 23, 7:51AM CST
The biotech sector is teeming with companies racing to bring the hot new drug or therapy to the marketplace. But realistically assessing the therapeutic potential of pipeline products is the healthy approach for selecting a winner. In this interview...
CPXX: 3.10 (+0.07), RPTP: 9.05 (-0.40), SRPT: 12.76 (+0.11), CLDX: 20.97 (+0.53), PTCT: 53.37 (-0.74), RMTI: 11.17 (+0.15), ATHX: 2.12 (unch), CUR: 3.41 (+0.13)
PDUFA date approaches for Rockwell's Triferic
Seeking Alpha - at Seeking Alpha - Thu Jan 22, 12:19PM CST
RMTI: 11.17 (+0.15)
Rockwell Medical Technologies Shares Up 17.6% Since SmarTrend's Buy Recommendation (RMTI)
Comtex SmarTrend(R) - Thu Jan 15, 9:33AM CST
SmarTrend identified an Uptrend for Rockwell Medical Technologies (NASDAQ:RMTI) on December 31st, 2014 at $10.07. In approximately 2 weeks, Rockwell Medical Technologies has returned 17.64% as of today's recent price of $11.84.
RMTI: 11.17 (+0.15)
NxStage Revises Up 2014 Guidance on Strong Home Growth - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 14, 4:15PM CST
NxStage Medical Inc. (NXTM) revised its fourth quarter and full year 2014 guidance.
NXTM: 17.56 (-0.05), BAX: 70.39 (+0.31), FMS: 36.43 (-0.65), RMTI: 11.17 (+0.15)
Rockwell Medical (RMTI) Jumps: Stock Moves 8.7% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 08, 8:25AM CST
Rockwell Medical (RMTI) was a big mover last session, with shares rising nearly 9% on the day.
ICUI: 88.98 (+0.42), RMTI: 11.17 (+0.15)
Rockwell Medical Announces Two Triferic Abstracts to be Presented at Annual Dialysis Conference Jan. 31 - Feb. 3, 2015 in New Orleans, Louisiana
GlobeNewswire - Wed Jan 07, 7:00AM CST
Rockwell Medical, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis, announced today that two individual abstracts for Triferic have been selected by the Annual Dialysis Conference for presentation at their Annual Meeting, January 31 - February 3, 2015 in New Orleans, Louisiana. Triferic is the Company's late-stage investigational iron-replacement drug for the treatment of iron deficiency in chronic kidney disease patients receiving hemodialysis.
RMTI: 11.17 (+0.15)
Nasdaq stocks posting largest percentage increases
AP - Tue Dec 30, 5:31PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
RESN: 16.62 (-1.38), ADXS: 7.18 (+0.06), ARWR: 6.77 (+0.21), LAKE: 10.18 (+0.89), RMTI: 11.17 (+0.15), ASYS: 9.87 (+0.30), SZMK: 6.53 (+0.10)
